Contact Wockhardt UK
Our Address Details Media enquiries
Wockhardt UK Limited Email: firstname.lastname@example.org
Ash Road North Call: Sara Wheater/Alex Brown +441244 567236
Wrexham Industrial Estate
LL13 9UF, U.K.
Tel: 01978 661261
Fax: 01978 660130
Registered in England & Wales No: 5835570
Download > the map and directions to our Wrexham office
To contact Wockhardt UK, please fill in your details and submit when complete.
Your enquiry will be forwarded to the appropriate person within Wockhardt UK for a prompt response.
(Fields with * must be filled out please)
Reporting of suspected side effects (adverse drug reactions)
The Drug Safety and Information Department processes drug information (medical) and pharmacovigilance (drug safety) enquiries, including suspected adverse drug reactions (side effects). Drug Safety and Information departments are prohibited from commenting on or providing advice on a patient’s medication or treatment. Patients and their representatives must discuss all matters of this nature with the patient's doctor.
If you get any side effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.
By reporting side effects, you can help provide more information on the safety of medicines.
Suspected side effects should also be reported to the Product Licence (PL) Holder. The PL Holder's name can be found on the product pack or in the Patient Information Leaflet/Package Leaflet. If you have a suspected side effect related to medication for which Wockhardt UK Limited is the PL Holder, please complete the form above - selecting the “report a suspected side effect” option - stating the PL Number for the product concerned.
All the information and personal data you share with the Company in your email enquiry will be protected and kept confidential in line with Wockhardt UK Limited's Company policy and local regulations. The information you provide will be used for the purpose of drug safety surveillance and will enable the Company to deal with your enquiry appropriately. If applicable, the information you provide may also be forwarded to medicines regulatory authorities in the European Union. You have a right of access to the personal data which the Company holds in relation to you.